Veterinary Vaccines Market Size to Reach Valuation of USD 12.75 Billion by 2027

The trend of using fewer antibiotics and the rising usage of vaccines as an effective treatment for zoonotic disorders are driving the veterinary vaccines market.

The global veterinary vaccines market is projected to value nearly USD 12.75 Billion by 2027. The growth of the market is attributable to the growing threats of zoonotic diseases and disorders coupled with the increasing inclination for using fewer harsh antibiotics.

Additionally, increasing incidences of livestock disorders are estimated to fuel the growth of the global veterinary vaccines market. However, the lack of appropriate standards, coupled with improved quality controls, is restraining the growth of the global veterinary vaccines market. Nonetheless, the increasing safety of medicines and vaccines is estimated to offer several opportunities for growth in the coming future.

Key Highlights of Report

  • In January 2020, Automazioni VX, Inc. and Merck Animal Health entered into a cooperative agreement for collaboration and to launch Innoject Pro. This technology is developed for subcutaneous injection vaccination of chicken to save them from infection.
  • Based on the type, the poultry sub-segment dominated the global veterinary vaccines market and is projected to witness faster growth by expanding at a CAGR of 7.0% during the forecast period. This growth is attributable to the factors such as increased demand for risk-free pet food and growing focus on the development of new animal protection practices.
  • Based on administration, the injection sub-segment is expected to lead in terms of market share by the end of the forecast period. This segmental growth is attributable to a surge in demand for injection vaccines for the protection of animal health.
  • Based on the technology, the inactivated sub-segment of the market is projected to dominate in terms of revenue and retain its dominance over the forecast period. This growth is attributable to the growing demand for inactivated vaccines as these offer flexibility in the shipping and preserving simple.
  • Based on infection type, the viral sub-segment is expected to remain dominant in the market during the forecast period owing to the growing prevalence of viral infections among livestock. Additionally, the viruses such as the Nipah virus infection, canine influenza, avian influenza, bird flu, and swine flu.
  • Regionally, the North America region is anticipated to dominate the global veterinary vaccines market over the forecast period. This growth is attributable to the rising incidence of animal diseases coupled with the rising population of pets in the U.S.
  • Key players operating in the global veterinary vaccines market include Bayer AG, Zoetis Inc., Virbac SA, Eli Lilly and Company, Merck KGaA, Phibro Animal Health Corporation, Aptimmune Biologics Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.

Grab Your Free Sample Copy Now

Emergen Research has segmented the global veterinary vaccines market based on type, administration path, technology, infection, and region.

  • Type Outlook (Revenue, USD Billion; 2017–2027)
    • Poultry
    • Swine
    • Aquaculture
    • Cattle
    • Cat
    • Dog
  • Administration Path Outlook (Revenue, USD Billion; 2017–2027)
    • Oral
    • Injection
    • Spray/Immersion
  • Technology Outlook (Revenue, USD Billion; 2017–2027)
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Toxoid
  • Infection Outlook (Revenue, USD Billion; 2017–2027)
    • Fungal
    • Bacterial
    • Parasitic
    • Viral
  • Regional Outlook (Revenue, USD Billion; 2017–2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. Rest of MEA

To get leading market solutions, visit the link below:

Biswas Debanjan

Debanjan Biswas is researcher in various sectors, including information technology, healthcare and automotive, with over a decade of experience in the industry.

Published by
Biswas Debanjan

Recent Posts

How Much Money Do I Need to Begin Trading Options?

While searching about options trading, you must explore various things that beneficially help you. It…

6 hours ago

Strike Crypto Gold With These Fantasy Sports Tips

Fantasy sports and crypto are more similar than you might think. Check out our top…

10 hours ago

Banking Leader Marwan Kheireddine Reflects on Bringing Credit Cards to Lebanon

Marwan Salim Kheireddine has held leading roles in the Lebanese banking sector for decades. As…

11 hours ago

An Introduction to BioTechniques and Next-Generation Sequencing

An overview of the latest in next-generation sequencing techniques and technologies. Next-generation sequencing (NGS), or…

11 hours ago

Role of AI in Probabilistic Matching for Customer Identity Unification

In today’s marketing world, the ability to generate and analyze customer data isn’t simply another…

11 hours ago

Could Altcoin Make a Comeback in 2022?

Since 2017, when several Bitcoin competitors flooded the cryptocurrency market, altcoin demonstrated its potential as…

11 hours ago